Phoenix Pharma
Marc Böckenholt currently serves as Strategic Assistant to the CFO at PHOENIX group, an Integrated Healthcare Provider, since October 2022. Prior experience includes roles at EY as a Senior Consultant and Consultant focused on strategy and reshaping results from October 2019 to October 2022, and an intern in M&A FIG in early 2018, where responsibilities included financial analysis and pitchbook preparation. Earlier internships at PwC, National-Bank AG, and RNR AG provided experience in business recovery services, corporate banking, and accounting, respectively. Educational qualifications include a Master of Science in Finance from Lancaster University and the International School of Management, along with a Bachelor of Arts in General Management from CBS International Business School.
Phoenix Pharma
2 followers
PHOENIX Pharmahandel Aktiengesellschaft & Co KG (PHOENIX Group), headquartered in Mannheim, Baden-Württemberg is the largest pharmaceutical wholesaler in Germany, and the second largest in Europe with about 20 distribution centers across the country delivering drugs to some 12,000 independent pharmacies. Its PHOENIX Documentation is an Internet-based archive offering detailed information on drugs, their components, indications, and effects. Formation of Holding company PHOENIX International Beteiligungs GmbH. Phoenix Group is majority owner of the pharmaceutical wholesalers Purus A.S. in the Czech Republic and Tamro in Finland. Phoenix Group itself is majority-owned by pharmaceutical conglomerate Merckle Group.